FTC v. Watson Pharmaceuticals, Inc.

U.S. Court of Appeals for the Eleventh Circuit

FTC v. Watson Pharmaceuticals, Inc.

Opinion

Case: 10-12729 Date Filed: 09/09/2013 Page: 1 of 2

[DO NOT PUBLISH]

IN THE UNITED STATES COURT OF APPEALS

FOR THE ELEVENTH CIRCUIT

________________________

No. 10-12729

________________________

D.C. Docket No. 1:09-cv-00955-TWT FEDERAL TRADE COMMISSION, Plaintiff -Counter Defendant- Appellant, versus WATSON PHARMACEUTICALS, INC., SOLVAY PHARMACEUTICALS, INC., Defendants - Appellees, PAR PHARMACEUTICAL COMPANIES, INC., PADDOCK LABORATORIES, INC., Defendants-Counter Claimants-Appellees.

________________________

Appeal from the United States District Court

for the Northern District of Georgia

________________________

(September 9, 2013)

Case: 10-12729 Date Filed: 09/09/2013 Page: 2 of 2

ON REMAND FROM THE SUPREME COURT

OF THE UNITED STATES Before CARNES, Chief Judge, KRAVITCH and FARRIS, * Circuit Judges. PER CURIAM:

The district court’s judgment, which was entered on April 21, 2010, is VACATED, and this case is REMANDED for further proceedings consistent with the Supreme Court’s opinion in F.T.C. v. Actavis, Inc., — U.S. —, 133 S.Ct. 2223 (2013).

*

Honorable Jerome Farris, United States Circuit Judge for the Ninth Circuit, sitting by designation.

2

Reference

Status
Unpublished